E Fund Management Co., Ltd. Karuna Therapeutics, Inc. Transaction History

E Fund Management Co., Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$161.01 - $317.85 $23,185 - $45,770	-144 Reduced 5.8%	2,338 $740,000
Q3 2023 Nov 13, 2023	BUY	$164.66 - $218.08 $85,458 - $113,183	519 Added 26.44%	2,482 $420,000
Q2 2023 Aug 11, 2023	SELL	$176.32 - $240.22 $34,206 - $46,602	-194 Reduced 8.99%	1,963 $426,000
Q1 2023 May 11, 2023	BUY	$161.33 - $204.36 $2,258 - $2,861	14 Added 0.65%	2,157 $392,000
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $43,860 - $54,231	229 Added 11.96%	2,143 $421,000
Q3 2022 Nov 14, 2022	SELL	$123.79 - $277.42 $297,343 - $666,362	-2,402 Reduced 55.65%	1,914 $431,000
Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $160,594 - $244,950	1,709 Added 65.55%	4,316 $546,000
Q1 2022 May 12, 2022	BUY	$98.9 - $132.37 $143,108 - $191,539	1,447 Added 124.74%	2,607 $331,000
Q1 2021 May 12, 2021	BUY	$95.46 - $133.08 $110,733 - $154,372	1,160 New	1,160 $139,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.